Groundbreaking research reveals nearly 5% of UK adults are turning to revolutionary weight loss injections like Wegovy and Mounjaro, with overwhelming majority paying privately amid NHS supply constraints.
Groundbreaking research shows weight loss injections like Wegovy and Ozempic do more than help shed pounds - they're linked to significant reductions in premature death from cancer, heart disease and diabetes.
Groundbreaking medical imaging uncovers alarming side effects of popular weight-loss drugs Ozempic and Wegovy that patients need to know about.
Hollywood star Amy Schumer showcases remarkable weight loss in stunning photoshoot while opening up about the 'nightmare' side effects of medication many suspect to be Ozempic.
Exclusive: Costco pharmacies begin selling revolutionary weight loss injections Wegovy and Ozempic at competitive prices, making groundbreaking treatments more accessible across Britain.
Warehouse giant Costco is now offering substantial discounts on popular weight loss medications Ozempic and Wegovy, making groundbreaking treatments more accessible to consumers across the UK.
Costco triggers shopping frenzy as it slashes Ozempic prices by 50% in UK warehouses, making the popular diabetes and weight loss medication more accessible than ever before.
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.
A woman's astonishing account reveals how dramatic weight loss transformed her social experience, exposing society's hidden bias toward thinner bodies and raising questions about 'pretty privilege'.
Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.
Exclusive: The NHS faces a financial timebomb as new analysis reveals prescribing weight-loss drugs like Wegovy could cost twice the entire current GP prescribing budget, sparking a national rationing debate.
New generation weight-loss medications are doing more than suppress appetite; they're fundamentally altering our psychological and emotional connections to eating, raising profound questions for individuals and society.
Model and TV personality Chrissy Teigen opens up in a raw and emotional interview about her Ozempic-fuelled weight loss journey and the tragic miscarriage she believes it caused, sparking a crucial conversation on medication safety.
Model and TV personality Chrissy Teigen breaks her silence on using diabetes drug Ozempic for weight loss, sparking debate on celebrity wellness trends and pharmaceutical ethics.
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.
A landmark UK study reveals the new weight loss injection Tirzepatide is significantly more effective than existing treatments, helping patients lose over 20% of their body weight and offering new hope in the fight against obesity.
Groundbreaking research reveals that blockbuster weight-loss jabs do more than suppress appetite—they may fundamentally change the brain's response to food, offering new hope for tackling compulsive eating disorders.
New research reveals that GLP-1 weight-loss injections not only aid in shedding pounds but also significantly quiet intrusive thoughts about food, offering a dual benefit for patients.
Groundbreaking NHS research reveals obesity injections like Wegovy are dramatically more effective than lifestyle changes alone for teenagers, offering new hope in the childhood obesity crisis.
Groundbreaking UK research suggests GLP-1 weight-loss injections, including Wegovy, may dramatically reduce the risk of obesity-related cancers, offering new hope in preventative oncology.
The NHS is rolling out a powerful new 4mg weekly injection of semaglutide, a 'game-changer' in weight loss treatment, as part of a major strategy to tackle the nation's obesity epidemic.
The NHS receives a powerful new weapon in the fight against obesity as medical regulators approve a higher 2.4mg dose of Wegovy, proven to help patients shed significantly more weight.
A British mother who lost eight stone using 'fat jabs' has sparked a fierce debate by arguing the NHS should not fund them for weight loss, calling it a personal lifestyle choice rather than an essential right.
UK health officials issue urgent safety alert for popular slimming injections like Ozempic and Wegovy. Patients must disclose use before operations to prevent dangerous complications.
Groundbreaking research from Tufts University reveals that drugs like Ozempic and Wegovy are dramatically more effective for weight loss than traditional diet and exercise alone, potentially transforming the NHS's approach to the obesity epidemic.
A new oral weight loss medication, Orforglipron, shows transformative potential in UK clinical trials, matching the efficacy of injectable treatments like Mounjaro and offering new hope for tackling obesity.
Exclusive: The NHS is now prescribing powerful diabetes medications Ozempic and Mounjaro for weight loss, sparking a massive surge in demand and a fierce debate over ethics and supply.
A UK mother's revelation that she uses her disability benefits to pay for weight-loss jabs like Wegovy has ignited a fierce national debate on welfare spending, medical ethics, and obesity treatment.
The World Health Organisation makes a landmark decision, adding weight-loss injections like Wegovy to its Essential Medicines List, signalling a new front in the global fight against obesity.